Note: This is an excerpt from a post published by NaturalNews.com and is shared in accordance with fair use terms for nonprofit educational purposes.
(Natural News) The website TrialSite News has obtained eye-opening documents showing that pharmaceutical giant Pfizer cut corners and slashed quality standards to rush its Wuhan coronavirus (Covid-19) vaccine into production at “warp speed.”
Pfizer and its German partner BioNTech failed to thoroughly examine biodistribution and pharmacokinetics issues related to their experimental gene therapy injection prior to submitting it to the European Medicines Agency (EMA) for review, we now know.
Biodistribution studies are designed to test where an injected compound travels throughout the body upon release, particularly with regards to vital organs and tissues. The purpose is to determine where a vaccine ends up so we know how people will react to it.
Instead of conducting a real one, though, Pfizer cut corners and used a “surrogate” mRNA injection that produces the luciferase protein rather than the BNT162b2 variety actually being administered to the public.
“No traditional pharmacokinetic or biodistribution studies have been performed with the vaccine candidate BNT162b2,” the EMA reviewers admitted about Pfizer’s fraudulent actions.
Regulatory documents also reveal that Pfizer failed to follow industry-standard quality management protocols during preclinical toxicology studies of its injection. These key studies did not meet good laboratory practice (GLP).
“Good laboratory practice or GLP is a set of principles intended to assure the quality and integrity of non-clinical laboratory studies used as the basis for research or marketing permits for products regulated by government agencies,” explains The Defender, a newsletter of Children’s Health Defense (CHD).
“The term GLP is most commonly associated with the pharmaceutical industry and the required non-clinical animal testing that must be performed prior to approval of new drug products.”
Pfizer lied about covid vaccine trials to rush out a dangerous injection
TrialSite founder and CEO Daniel O’Connor says that Pfizer was basically trying to accelerate the vaccine development timeline to get its injection on the market as quickly as possible. This is what was expected from Donald Trump’s “Operation Warp Speed” program.
Author: Ethan Huff
Ethan Huff is an independent freelance journalist and NaturalNews.com Contributor. He writes about a wide range of topics including health and science. His posts have appeared in many media outlets including Natural News, Epoch Times, InfoWars, People’s Taliba, News Rescue, Australian National Review, and Ozarks Farm and Neighbor.
© 2021, Z3 News. The first 200 words of Z3 News articles may be shared online in exchange for a clickable link to our site. Please include the author name and do not make any changes to text or titles. No image files from our site may be shared because we don’t own them. For permission to use our content in other formats, please contact us.